What about pleiotropic modifiers of preprocedural pro-inflammatory and pro-oxidant milieu in patients undergoing drug eluting stent implantation?
The exact pathophysiological mechanisms of coronary in-stent restenosis (ISR) has not yet been fully elucidated. Inflammation is known as the most commonly encountered pathway. Medications for cardiometabolic risk factors as the modifiers of preprocedural pro-inflammatory and pro-oxidant milieu shou...
| Príomhchruthaitheoir: | |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
KARE Publishing
2015-11-01
|
| Sraith: | Türk Kardiyoloji Derneği Arşivi |
| Ábhair: | |
| Rochtain ar líne: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-85055 |